GeneDx ( WGS 13.08%) shareholders are having quite a spectacular week, and it's not over yet. On Wednesday, the company's ...

That earnings report, unveiled well before market open that day, revealed that GeneDx booked nearly $103 million in revenue.

GeneDx beat Q2 estimates, raised guidance, and is seeing rapid test volume growth and stronger reimbursements. Check out why ...

GeneDx Holdings Corp. WGS is slated to report second-quarter 2025 results on July 29, before the market opens. The renowned genetic testing company reported first-quarter adjusted earnings of 28 cents ...

GeneDx Holdings (NASDAQ:WGS) stock is trading higher on Tuesday. The genetic testing company reported a third-quarter EPS loss of $ (0.31), compared to $ (1.64) reported a year ago, beating the ...